Improvements in Pain Interference
In an article in the Canadian Journal of Anaesthesia, researchers investigated patients attempting to get medical cannabis for their chronic pain. Researchers looked at the long-term effect of cannabis on these patients through patterns of cannabis use and primary outcomes—pain intensity and interference scores—along with questionnaire answers related to depression/anxiety, neuropathic pain, quality of life, adverse events, and self-reported opioid consumption at baseline, 3, 6, and 12 months,
Of >750 participants, >85% wanted cannabis to relieve their pain. >42% were taking opioids at baseline; 29.3% at 12 months. Half of those who completed the study were still taking opioids at the 12 month follow up. The study concluded that “approximately one-third of patients in the cohort remained on medical cannabis for six months. In this cohort, pain intensity and pain-related interference scores were reduced and QoL and general health symptoms scores were improved compared with baseline.”
Access the journal article.
Did you enjoy this article?
Subscribe to the PAINWeek Newsletter
and get our latest articles and more direct to your inbox